Company / Gross Profit per Share
Progyny Gross Profit per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$3.57
FY2025
5-year range
$1.12 / $3.57
FY2021-FY2025
Trend
+35.7%
vs FY2024
Sector context
#79 of 94
Health Care
What the data says
Progyny's gross profit per share of $3.57 is lower than 84% of companies in the Health Care sector (FY2025). Gross Profit per Share has increased for 5 consecutive years, from $0.71 in FY2020 to $3.57 in FY2025.
Based on SEC 10-K filings.
3.57 in FY2025 with a 5-year CAGR of +38.2%.
Improved from $2.56 to $3.57 over the past 2 years.
Health Care sector context is included.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- +24.8%
- 5-Year CAGR
- +38.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 94This company $3.57 Sector average $14.29
▼
-75.0% below sector average
Key checks
Key Insights
- Progyny's gross profit per share has grown for 5 consecutive years.
- In FY2025, gross profit per share increased 35.7% year-over-year.
- Ranks #79 out of 94 companies in the Health Care sector.
- Lowest gross profit per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.57 | +35.7% |
| FY2024 | $2.63 | +2.7% |
| FY2023 | $2.56 | +39.3% |
| FY2022 | $1.84 | +64.4% |
| FY2021 | $1.12 | +58.0% |
| FY2020 | $0.71 | -67.8% |
| FY2019 | $2.19 | -37.4% |
| FY2018 | $3.51 | +169.2% |
| FY2017 | $1.30 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026